The global respiratory diseases testing market is
expected to reach USD 6.7 billion by 2025, according to a new report by Grand
View Research, Inc. The market is driven by the rising prevalence of
respiratory diseases. As per Forum of International Respiratory Societies, more
than 200 million people across the globe suffered from Chronic Obstructive
Pulmonary Disease (COPD) and 235 million suffered from asthma in 2014. In
addition, the source stated that more than 50 million people struggle with
occupational lung diseases annually. Thus, constantly growing target patient
population is anticipated to drive the growth.
The adoption of innovative technologies,
such as Computed Tomography (CT), for COPD diagnosis is expected to drive the
growth. The other new technology in acute medical management of COPD is pulse
oximeter that is used for outpatient monitoring. Airway management plays
a main role in testing and management of COPD. Also, with recent technological
innovations, there has been a 12.1 % increase in the use of Noninvasive
Mechanical Ventilation (NIV) for management of COPD. Along with technological
advancements, use of digital radiography (X-ray) and advanced portable
spirometers is gaining momentum in the market.
Browse full report by Grand View
Research : http://www.grandviewresearch.com/industry-analysis/respiratory-disease-testing-market
Further key findings from the study suggest:
·
The growing prevalence of COPD and asthma
across the globe is expected to increase the demand for respiratory disease
testing devices and thereby drive the market growth
·
In products, imaging tests held the largest
share in 2016 due to rapid development and adoption of innovative technologies
·
In respiratory measurement, spirometers,
pulse oximeters, ventilators, capnographs, and other noninvasive ventilators
used for measurement of lung capacity are expected to grow at a rate of more
than 4% over the forecast period
·
In end-use, hospitals segment held the
largest share in 2016 and is anticipated to grow over the forecast period
·
North America the largest market share in
2016. Growing prevalence of respiratory diseases such as COPD, asthma is
increasing the demand for respiratory disease testing/diagnostic in North
American countries.
·
Asia Pacific region is expected to grow at
the fastest rate during the forecast period. This growth can be attributed to
various factors such as improving health care infrastructure and increasing
patient awareness regarding the availability of new diagnostic techniques for
respiratory diseases, such as COPD & asthma.
·
Some of the major players competing in this
market include, but are not limited to, Becton Dickinson (Carefusion
Corporation); Koninklijke Philips N.V. (Respironics); ResMed Company;
Fischer & Paykel; and Medtronic. These players are strong brands in the
market as they have elaborate product portfolios in respiratory disease testing
market.
View more reports of this category by Grand View Research
at: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the
respiratory disease testing/diagnostics market by product, end-use and regions.
Product Outlook (Revenue, USD Million; 2014 - 2025)
·
Imaging test
·
Respiratory Measurement
·
Blood gas test
·
Other
End-use Outlook (Revenue, USD Million; 2014 - 2025)
·
Hospitals
·
Physician clinics
·
Clinical laboratories
·
Others
Regional Outlook (Revenue, USD Million; 2014 - 2025)
·
North America
o U.S.
o Canada
·
Europe
o Germany
o UK
·
Asia Pacific
o China
o Japan
·
Latin America
o Mexico
o Brazil
·
MEA
o South Africa
View press
release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-respiratory-disease-testing-diagnostics-market
About Grand
View Research
Grand View Research, Inc. is a U.S. based market research and consulting
company, registered in the State of California and headquartered in San
Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
